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SINcE the first observation of Foley (1953) it has been well substantiated that
sarcomas induced in mice by polycycic hydrocarbons are antigenic in isogenic
(Old et al., 1962; Prehn, 1960; Prehn and Main, 1957), and even in autochthonous
hosts (Klein et al., 1960; Revesz, 1960). More recently, the isoantigenic proper-
ties of other tumours have been studied: leukaemia, induced by X-irradiation
(Koldovsky, 1962) by the Gross virus (Klein, Sj6gren and Klein, 1962), polyoma-
induced sarcomas (Habel, 1961; Sj6gren, Hellstrom and Klein, 1961), mammary
tumours, and pulmonary adenomas (Prehn, 1962). The present communication
is concerned with a study of the antigenic properties of hepatomas, induced in
Lewis rats by 4-dimethylaminoazobenzene (DAB). The results to be described
suggest that these hepatomas are antigenic in isogenic hosts.
MATERIALS AND METHODS
Tumour induction
Lewis rats, members of a highly inbred strain were purchased from Micro-
biological Associates Inc. Fifty male rats, weighing 200 ± 10 g. were placed on a
carcinogenic diet, while one couple was used to start a breeding colony: brother-
sister mating was strictly maintained. Rats from this colony served for all
subsequent experiments.
The carcinogenic diet used was diet number 3 of Miller et al. (1948) containing
0*06% 4-dimethylaminoazobenzene (DAB). Rats maintained on this diet for a
100 to 132 days were returned to a normal diet ofPurina Fox Chow. They were
inspected weekly and when a tumour became palpable, the animal was killed
by decapitation and the tumour was quickly excised and was placed in chilled
Ringer solution.
Connective tissue and necrotic portions of the tumour were discarded and
fragments of the clean tumour were fixed for histology, some frozen in a mixture
of dry ice and alcohol for storage, and others were used for transplantation.
Tumour tissue for histological examination was fixed in Carnoy solution and
sections wereprepared by standard histological procedures. Sections were stained
with haematoxylin and eosin.
Transplantation of tumour fragments was performed using a No. 12 or No. 13
trocar: each recipient was given two injections subcutaneously in the abdominal
region.
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Immunological experiments
The procedure for immunization consisted in allowing the tumour to grow in
the recipient animal and excising it after it has grown to approximately 1 cm.
diameter. Immunity was tested by challenging the animal, free of tumour, by
the implantation of tumour derived from the same source as that used for the
immunization. Immunity was demonstrated if the tumour failed to grow, or
grew at a slower rate than in non-immunized controls.
Tumours which grew as a result ofthe challenging injection were again excised,
and the animals now having had two courses of immunization were challenged a
second time. In some cases this procedure was repeated a third time. Control
animalsfrom eachpreviousexperiment, freed oftheirtumour, served asimmunized
animals in the subsequent experiment. All the rats which were challenged twice
or three times with tumour fragments were finally challenged with a suspension of
tumour cells.
For immunization two pieces of tumour were implanted subcutaneously in
the abdominal region using a No. 12 trocar. For challenge with tumour fragments
the injections were made with a No. 13 trocar above the ribs on either side. For
challenge with cellsuspensions thenumber ofviable cellsinjected wasthe minimum
that would take in the majority ofunimmunized male controls. This number was
determined in preliminary experiments.
The suspension of tumour cells was prepared from freshly excised tumours.
The tumours were cleaned from connective tissue and necrotic portions. They
were then minced with scissors and passed through a stainless steel sieve. The
suspension was diluted with cold, sterile Ringer solution to give a final concentra-
tion of 10-300 x 106 viable cells/ml. Cell viability was determined by the
dye-exclusion method of Schrek (1936).
In the first experiments primary and first transplant generation tumours were
used for immunization and challenge respectively. In subsequent experiments
tumours which have undergone as many as 13 successive transplantations have
been used.
RESULTS
Tumour induction
Of 50 animals on a carcinogenic diet, 26 died within the first 132 days with
no detectable tumour. Of-the 24-animals remaining, 2 were transferred to normal
diet after 94 days of DAB feeding, 22 after 119 to 132 days of carcinogenic diet.
The 2 animals in the first group were free oftumour 6 months later, while 21 out of
the 22 animals of the second group developed liver tumours. (Post-mortem
examination was not carried out on the 22nd animal.) The tumours were first
detectable 29-161 days after the animals were returned to normal diet. In
general the longer was the exposure to the carcinogenic diet the shorter became
the latent period on normal diet. The average time required for the development
of tumour was 71 months; 41 months on the carcinogenic diet, followed by
3 months on normal diet. Six of the tumours (TI, 9, 10, 13, 14 and 15) were
identified as being hepatomas, one as a cholangioma (T12) and there was one
mixed tumour (Tll). The remaining 12 could not be classified as there were no
sections made oftheprimary tumours. -
Fifteen of the 22 tumours obtaidbd were transplanted into both male and
female Lewis rats; they were each found to be freely transplantable in rats of
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both sexes provided a large enough transplant was used. However, using small
doses of cell suspensions only 1 tumour grew in 20 females injected as compared to
40 takes in 56 males. The minimum number ofviable cells to take in the majority
of male recipients varied from 3-2 to 12-5 million cells injected.
Immunological experiments
Results obtained using tumour fragments for challenge are shown in Table I.
In 12 experiments using 10 different tumours, only in 2 cases is there an appre-
TABLE I.-Tumour Incidence in Rats Challenged with
Tumour Fragments
Tumour* Untreated: Immunized:
control (c3) ( 3)
TI 1/4 0/2
T4 . 5/5 7/9
T4t 6/6 10/10
T5t. 2/5 3/11
T5t 6/6 8/8
T7 4/4 14/16
T8 4/4 8/9
T9 3/5 2/7
T10 2/2 2/2
Tll 5/5 4/5
T12 3/4 2/4
T13 4/5 . 4/4
* The letter T stands for "tumour" while the numbers (1 to 13) designate the turrour line.
t The animals freed of their tumouirs arising from the first challenge were challenged a second
time.
I Number of tumours growing/animals injected.
ciable difference in tumour incidence between controls and immunized animals
(T5, T9). With T7 and T8, although 14 out of 16 and 8 of 9 tumours grew in the
immunized groups, they appeared later than in the respective controls. If these
differences indeed represent a low degree of immunity in the pretreated animals,
it was felt that this could be better studied using a more sensitive test system.
Such a system was obtained by using for challenge the lowest cell dose capable of
eliciting tumours in the majority of untreated controls. Results presented in
Table II suggest that immunity is demonstrable in most instances using this
system. With T14 there were no takes in immunized animals at the termination
of the experiment nor were any with T8, although with the latter the tumour
incidence in the control group was low. With T6, only 50% of the immunized
animals had tumours as compared to 90o% in the controls. With T9 and Ti1,
immunity was manifested only by a retardation of growth. In the case of T5,
the cell dose used appears to be too low, as the tumour did not grow in the
untreated males; fragments of the same tumour took in 100 % of the recipients.
In contrast, the dose used of T12 was too high as evidenced by a 100 % incidence
in the female controls. This latter observation proved to be useful to judge
whether conditions were favourable to demonstrate immunity: for optimal
results a cell dose had to be selected which took in the male controls, but did not
grow in the females. In no instance could immunity be detected using a cell dose
high enough to grow out in untreated females. Thus eliminating the results390 J. GORDON
TABLE II.-Tumour Incidence in Rats Challenged with a
Suwpension of Tumour Cells
Challenged with
A , Days Untreated Untreated Immunized
number of transplant after control control
Tumour cells x 106 generation challenge 6C Is
T5* . 4 . 10 . 61 015t . 1/12 . 0/13
9*7 . 12 . 52 . 0/5 . 0/12 . 0/13
T6 . 4*5 . 5 . 68 . 0/5 * 9/10 . 5/10
T8 . 4 . 8 . 59 . 0/5 . 2/12 . 0/7
T9 . 6 . 13 . 11 . not . 5/5 . 3/6
25 . done . 5/5 . 5/6
T1l . 3*5 . 5 . 20 . 0/5 . 8/10 . 2/9
68 . 10/10 . 7/9
T12 . 3*2 . 12 . 39 . 5/5 . 10/11 . 4/4
T14 . 4*3 . 7 . 55 . 1/5 . 9/11 . 0j6
Total: .33/46 (72%). 10/38 (26%)
* The letter T stands for "tumour " while the number (1 to 14) designates the tumour line.
t Number oftumours/animals injected.
t The total was computed with the exclusion of T5 and T12; in the case of T9 and Til the
figures tak-en were those at 11 days and 20 days after transplantation respectively. For explanation
see text.
obtained with T12 where the cell dose used was too high and T5, where the dose
was too low, the total tumour incidence in the control group was 33 out of 46, or
72 % as compared to 10 out of 38 or 26 % among the immunized animals.
The resistance of untreated female rats to accept the tumours (originally
induced in males) is probably immunological in nature: trocar pieces of tumours
took regularly in untreated females while they failed to grow in females pre-
immunized with the tumour. Ti grew in 3 out of 4 females injected but none
grew in 7 pre-immunized rats. Similarly Tll grew in 2 out of 4 female controls
but none took in 5 immune animals.
DISCUSSION
4-Dimethylaminoazobenzene (DAB) has been found to be more toxic for the
Lewis than for the Wistar rats. Over 50 per cent of the animals died during the
first 4 months of carcinogenic regime and, had the 24 surviving rats not been
transferred to a normal diet, the mortality would have been considerably higher.
The tumours induced arose later than in Wistar rats given the same carcinogen
and, the biochemical characteristics ofthe tumours ofthe two sources also differed
(De Lamirande and Gordon, 1964). These differences observed point to the
importance ofhost factors in carcinogenesis.
The immunological experiments summarized in Table II indicate that tumour
incidence and the rate ofgrowth of tumours in the immunized group was smaller
than in the control group of rats. These differences cannot be attributed to
residual heterozygozity among the Lewis rats as skin grafts exchanged among
8 rats bred in this laboratory were still intact 67 days after grafting.* Thus it
would appear that hepatomas induced by an azo dye, similarly to sarcomas,
induced by polycyclic hydrocarbons, possess tumour specific antigens; however
further experiments, using larger number of animals will have to settle this ques-
tion.
* These experiments were performed by Dr. M. E. Dixon, Department of Experimental Surgery,
McGill University.ISOANTIGENICITY OF LIVER TUMOURS 391
SUMMARY
Hepatomas and a cholangioma were induced in male Lewis rats of a highly
inbred strain by feeding 4-dimethylaminoazobenzene. The tumours obtained
were freely transplantable in Lewis rats.
The incidence and rate ofgrowth ofthe tumours in controls and pre-immunized
Lewis rats was compared: tumours grew in 33 out of 46 control rats (72 %) as
compared to 10 out of 38, or 26% of the immunized animals suggesting, that the
hepatomas induced possess tumour specific antigen(s).
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